Literature DB >> 22926620

Agomelatine may improve REM sleep behavior disorder symptoms.

Anastasios Bonakis, Nicholas-Tiberio Economou, Sokratis G Papageorgiou, Emmanuil Vagiakis, Serafeim Nanas, Thomas Paparrigopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22926620     DOI： 10.1097/JCP.0b013e31826866f8

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  11 in total

Review 1.  Melatonin therapy for REM sleep behavior disorder: a critical review of evidence.

Authors:  Ian R McGrane; Jonathan G Leung; Erik K St Louis; Bradley F Boeve
Journal:  Sleep Med       Date:  2014-10-13       Impact factor: 3.492

2.  Insomnia and dementia: is agomelatine treatment helpful? Case report and review of the literature.

Authors:  Vesile Altınyazar; Nefati Kiylioglu
Journal:  Ther Adv Psychopharmacol       Date:  2016-05-16

3.  An Open-Labeled Trial of Ramelteon in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.

Authors:  Yuichi Esaki; Tsuyoshi Kitajima; Shigefumi Koike; Hiroshige Fujishiro; Yasuyo Iwata; Akiko Tsuchiya; Marina Hirose; Nakao Iwata
Journal:  J Clin Sleep Med       Date:  2016-05-15       Impact factor: 4.062

4.  Antidepressants Increase REM Sleep Muscle Tone in Patients with and without REM Sleep Behavior Disorder.

Authors:  Stuart J McCarter; Erik K St Louis; David J Sandness; Katlyn Arndt; Maia Erickson; Grace Tabatabai; Bradley F Boeve; Michael H Silber
Journal:  Sleep       Date:  2015-06-01       Impact factor: 5.849

Review 5.  Treatment of REM Sleep Behavior Disorder.

Authors:  Youngsin Jung; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2016-11       Impact factor: 3.598

Review 6.  REM sleep behaviour disorder in Parkinson's disease (Review).

Authors:  Ștefania Diaconu; Oana Falup-Pecurariu; Diana Țînț; Cristian Falup-Pecurariu
Journal:  Exp Ther Med       Date:  2021-05-28       Impact factor: 2.447

Review 7.  Therapeutic Symptomatic Strategies in the Parasomnias.

Authors:  Raffaele Manni; Gianpaolo Toscano; Michele Terzaghi
Journal:  Curr Treat Options Neurol       Date:  2018-06-05       Impact factor: 3.598

8.  Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT1 receptor as well as BDNF expression in the hippocampus during the subjective light phase of rats exposed to chronic constant light.

Authors:  Jana Tchekalarova; Lidia Kortenska; Natasha Ivanova; Milena Atanasova; Pencho Marinov
Journal:  Psychopharmacology (Berl)       Date:  2019-11-13       Impact factor: 4.530

Review 9.  Current Concepts and Controversies in the Management of REM Sleep Behavior Disorder.

Authors:  E Matar; S J McCarter; E K St Louis; S J G Lewis
Journal:  Neurotherapeutics       Date:  2021-01-06       Impact factor: 7.620

Review 10.  A Stage-Based Approach to Therapy in Parkinson's Disease.

Authors:  Claudia Carrarini; Mirella Russo; Fedele Dono; Martina Di Pietro; Marianna G Rispoli; Vincenzo Di Stefano; Laura Ferri; Filomena Barbone; Michela Vitale; Astrid Thomas; Stefano Luca Sensi; Marco Onofrj; Laura Bonanni
Journal:  Biomolecules       Date:  2019-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.